Joel Dunn

Combination of baseline metabolic tumour volume and early response on PET/CT improves progression-free survival prediction in DLBCL

N. George Mikhaeel, Daniel Smith, Joel Dunn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2016 · 303 citations · Full text

Attenuation of Insulin-Evoked Responses in Brain Networks Controlling Appetite and Reward in Insulin Resistance

Karen Anthony, Laurence Reed, Joel Dunn et al. · Diabetes · 2006 · 191 citations · Full text

Affective Neuroscience, Insulin Signaling, Social Sciences +26

[18F]FDG PET/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1

Victoria Warbey, Rosalie E. Ferner, Joel Dunn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 155 citations

Neuro-oncology, Tumor Innervation, Medicine +8

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma

Hajira Ilyas, N. George Mikhaeel, Joel Dunn et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2018 · 144 citations · Full text

Lymphoid Neoplasia, Translational Medicine, Radiology +10

Differential effects of teriparatide on regional bone formation using 18F-fluoride positron emission tomography

Michelle L. Frost, Musib Siddique, Glen M. Blake et al. · Journal of Bone and Mineral Research · 2010 · 79 citations